Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K153559
    Date Cleared
    2016-08-26

    (256 days)

    Product Code
    Regulation Number
    890.5860
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    Accelerated Care Plus (ACP)

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The OmniVersa™ Multi Modality Therapy and Omnistim® FX2 Professional Therapy Systems by ACP use the Omnistim® FX2 Stimulator for the following indications for use:

    • · Relaxation of muscle spasms
    • · Re-education of muscle
    • · Prevention or retardation of disuse atrophy
    • · Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis
    • Increases local circulation
    • · Maintains or increases range of motion

    Stimulator waveforms: IFC, LVPC, and VMS:
    · Symptomatic relief and management of chronic intractable pain and as an adjunctive treatment of acute pain, post-surgical pain and pain associated with post-traumatic injury.

    Electrical muscle stimulator devices should be used under medical supervision for adjunctive therapy for the treatment of medical diseases and conditions.

    The OmniVersa™ Multi-Modality Therapy System also uses Omnisound® Ultrasound Transducer(s) for the following indications for use:

    • Relieves pain
    • · Decreases joint stiffness and contractures
    • · Reduction of muscle spasm
    • · Increases local circulation
    • · Relief of pain, muscle spasms, and joint contractures that may be associated with: adhesive capsultiis, bursitis with slight calcification, myositis, soft tissue injuries, shortened tendons due to past injuries and scar tissues
    • · Relief of sub-chronic, chronic pain and joint contractures resular tightness, capsular scaring
    Device Description

    Not Found

    AI/ML Overview

    I am sorry, but the provided text from the FDA 510(k) letter for the OmniVersa™ Multi-Modality Therapy System and Omnistim® FX2 Professional Therapy System does not contain information about acceptance criteria or a study proving a device meets these criteria in the context of AI/ML performance.

    This document is a letter from the FDA determining substantial equivalence for a medical device (an ultrasound and muscle stimulator). It outlines:

    • The trade/device name and regulatory classification.
    • The indications for use of the device.
    • Regulatory compliance requirements.

    It does not include:

    • Information about a study on device performance against specific acceptance criteria.
    • Any mention of AI or machine learning.
    • Details on sample sizes, ground truth, expert qualifications, or adjudication methods for any performance studies.
    • Data on multi-reader multi-case (MRMC) comparative effectiveness or standalone algorithm performance.

    Therefore, I cannot fulfill your request for the specific details outlined in your prompt based on the provided text.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1